Chapter 3 Market and Technology Background
- Market Definition
- Ethics and Cognition and Memory-enhancing Drugs
- Treatments Available for Dementia
- Cholinesterase Inhibitors
- Memantine
- Nondrug Treatments for Dementia
- Availability of Dementia Treatments
- Treatment for Other Symptoms of Dementia Including Aggression and Anxiety
- Side Effects of Cognition and Memory-enhancing Drugs
- Benefits and Side Effects of Consuming Cognition Drugs
- Guidance Given by the American Academy of Neurology
- Current Cognition Enhancers
- Physical Exercise
- Diet and Nutrition
- Social Engagement
- Sleep
- Computer Training Programs
- ADHD Drugs, Symptoms, and Side Effects
- Use of Pharmacological Cognitive Enhancers by Healthy Individuals
- Enhancement of Executive Functions
- Use of Cannabis in Adolescence
- Use of Illicit and Prescription Drugs for Cognitive or Mood Enhancement Among Surgeons
- Study Reported in BMC Medicine in 2013 and Other Studies
- Executive Functions
- Working Memory
- Neuropsychiatric Disorders
- Enhancer Drug Use Trends Among Youth
- Future Prediction of Social Acceptance of Cognition and Memory-enhancing Drugs
- Patent Litigation Claims in the Cognition and Memory-enhancing Drugs Market
- Different Patent Infringement Types
- Clinical Guidelines
- Clinical Guidelines for Cognitive and Behavioral Problems in Dementia
- Clinical Practice Guidelines for Dementia in Australia
- Technology Trends
- Recent Studies Highlighting Potential of Cognition Drugs in Chess
- Market Dynamics
- Drivers
- Restraints
- Opportunities
Chapter 4 Global Cognition and Memory-enhancing Drugs Market Breakdown by Product Type
- ADHD, Attention Deficit Hyperactivity Disorder; MPH, Methylphenidate
- Prohibition of Cognition Enhancers in Healthy Individuals
- Global Cognition and Memory-enhancing Drugs Market
- Aricept
- Exelon
- Reminyl
- Namenda
- Adderall
- Ritalin
- Dexedrin
- Other Cognition and Memory-Enhancing Products
Chapter 5 Global Cognition and Memory-enhancing Drugs Market Breakdown by Application
- Alzheimer's Disease
- Brain Changes Associated with Alzheimer's Disease
- Mild Cognitive Impairment (MCI) - A Potential Precursor to Alzheimer’s and Other Dementias
- Recent Case Study on Alzheimer's Disease Drug: 2017
- Case Study on Alzheimer's Disease Drug: 2015
- Mortality and Morbidity Because of Alzheimer's Disease
- Healthcare Expenditure on Alzheimer's Disease
- Emergence of Biomarkers as Diagnostic Tool for Alzheimer's Disease
- Alzheimer's Disease Facts
- Difference between Alzheimer's Disease and Dementia
- Susceptibility Factors for Alzheimer's Disease
- Causes of Alzheimer's Disease
- Diagnosis of Alzheimer's Disease
- Screening of Other Health Conditions of People Suffering from Alzheimer's Disease
- Importance of Comprehensive Clinical Evaluation in the Case of Alzheimer's Disease Patients
- Education Sector
- Sports
- Other Applications
- Cognitive Impairment in People Suffering from Parkinson's Disease
- Treatment of Parkinson's Disease Dementia
- Cognitive Decline in Patients Suffering from Parkinson's Disease Causing Further Complexities
Chapter 6 Global Cognition and Memory-enhancing Drugs Market Breakdown by Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia
- ROW
- Brazil
- Turkey
- South Africa
Chapter 8 Analysis of Market Opportunities
- Product Approval
- Business Collaboration
Chapter 9 Company Profiles
- ACCELERATED INTELLIGENCE INC.
- Overview
- Products
- ALLERGAN PLC
- Overview
- Products
- ALTERNASCRIPT LLC
- Overview
- Products
- CAMBRIDGE COGNITION
- Overview
- Products
- CERETROPIC
- Overview
- Products
- COGNITION THERAPEUTICS INC.
- Overview
- Products
- COGSTATE LTD.
- Overview
- Products
- HVMN
- Overview
- Products
- NOOTRIMENT
- Overview
- Products
- NOVARTIS AG
- Overview
- ONNIT LABS LLC
- Overview
- Products
- PEAK NOOTROPICS
- Overview
- Products
- PFIZER INC.
- Overview
- Products
- PURELIFE BIOSCIENCE CO., LTD.
- Overview
- Products
- SHIRE
- Overview
- Products
- SUPNOOTROPIC BIO CO., LTD.
- Overview
- Products
- TEVA PHARMACEUTICALS INDUSTRIES LTD. (BARR PHARMACEUTICALS)
- Overview
- Products
Chapter 10 Appendix: Patents, Drugs and Cognitive Enhancers
- List of Patents North America
- List of Patents Applied Globally
- List of Drugs and Cognitive Enhancers
- 1,3-Dimethylamylamine
- 5-HTP
- Acetyl L-Carnitine
- Adrafinil
- Agmatine
- Alpha-GPC
- Alpha-Lipoic Acid
- Aniracetam
- Bacopa Monnieri
- Blueberry
- Boswellia Serrata
- Caffeine
- CDP-Choline
- Celastrus Paniculatus
- Clitoria Ternatea (Shanka Pushpi)
- Cocoa Flavanols
- Coluracetam
- Convolvulus Pluricaulis (Shankhapushpi)
- Creatine
- D-Serine
- Dehydroepiandrosterone
- Dimocarpus Longan
- Emblica Officinalis (Amla)
- Fish Oil (DHA, EPA, Omega-3)
- GABA
- Ginkgo biloba
- Glycine
- Gotu Kola (Centella Asiatica)
- Grape Seed Extract
- Green Tea Catechins
- Hordenine
- Huperzine-A
- Idebenone
- Kava
- Krill Oil
- L-DOPA
- L-Tyrosine
- Magnolia Officinalis
- Melissa Officinalis (Lemon Balm)
- Modafinil
- Morus Alba
- Mucuna Pruriens
- Muira Puama
- Nardostachys Jatamansi
- Nefiracetam
- Nicotine
- Nigella Sativa
- Noopept
- Oxiracetam
- Panax Ginseng
- Phenylethylamine
- Phenylpiracetam
- Phosphatidylserine
- Piracetam
- Polygala Tenuifolia
- Pramiracetam
- PRL-8-53
- Pueraria Lobata
- Pycnogenol
- Pyritinol
- Resveratrol
- Rhodiola Rosea
- S-Adenosyl Methionine
- Sarcosine
- Scutellaria baicalensis
- Sulbutiamine
- Sunifiram
- Theanine
- Uridine
- Vinpocetine
- Vitamin B12
- Yamabushitake
- Yerba Mate
- Zinc
List of Tables
Summary Table: Global Market for Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 1: Key Trends in Global Cognition Drugs and Memory Enhancers
Table 2: Drugs Used to Enhance Cognitive Function
Table 3: Global Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 4: Global Market for Aricept, by Region, Through 2022
Table 5: Global Market for Exelon, by Region, Through 2022
Table 6: Administration of Exelon
Table 7: Global Market for Reminyl, by Region, Through 2022
Table 8: Companies Manufacturing Reminyl
Table 9: Global Market for Namenda, by Region, Through 2022
Table 10: Global Market for Adderall, by Region, Through 2022
Table 11: Global Market for Ritalin, by Region, Through 2022
Table 12: Global Market for Dexedrin, by Region, Through 2022
Table 13: Global Market for Other Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 14: Causes of Dementia and Associated Characteristics
Table 15: Global Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 16: Global Cognition and Memory-enhancing Drugs Market for Alzheimer’s Disease, by Region, Through 2022
Table 17: Causes of Dementia and Associated Characteristics
Table 18: Global Cognition and Memory-enhancing Drugs Market in the Education Sector, by Region, Through 2022
Table 19: Global Cognition and Memory-enhancing Drugs Market in Sports, by Region, Through 2022
Table 20: Global Cognition and Memory-enhancing Drugs Market in Other Applications, by Region, Through 2022
Table 21: Global Market for Cognition and Memory-enhancing Drugs, by Region, Through 2022
Table 22: North American Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 23: North American Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 24: North American Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 25: European Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 26: European Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 27: European Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 28: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 29: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 30: Asia-Pacific Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 31: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Country, Through 2022
Table 32: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Product, Through 2022
Table 33: Rest of the World Market for Cognition and Memory-enhancing Drugs, by Application, Through 2022
Table 34: Patent Review of Cognition Drugs Market, 2013-2016
Table 35: Patent Review of Cognition Drugs Market, by Region, 2013-2016
Table 36: Allergan’s Financials, 2014-2016
Table 37: Allergan’s Developments, 2014-2017
Table 38: Cognition Therapeutics' Developments, 2014-2017
Table 39: Novartis’ Financials, 2014-2016
Table 40: Novartis’ Developments, 2014-2017
Table 41: Pfizer’s Financials, 2014-2016
Table 42: Pfizer’s Developments, 2014-2017
Table 43: Shire’s Financials, 2014-2016
Table 44: Teva’s Financials, 2014-2016
Table 45: Teva’s Developments, 2014-2017
Table 46: List of Patents, North America
Table 47: List of Patents Applied Globally
List of Figures
Summary Figure: Global Market for Cognition and Memory-enhancing Drugs, by Region, 2016-2022
Figure 1: Medication Overdose: Cognitive Impairment
Figure 2: Acetylcholinesterase Inhibitor Used in the Alzheimer’s Disease Management
Figure 3: Role of Modafinil in the Management of Alzheimer’s Disease
Figure 4: Off-license use of Pharmacological Cognitive-Enhancing Drugs
Figure 5: Risk Associated with the Excessive Use of Cannabis
Figure 6: Role of Adolescence in the Cognition Process
Figure 7: Statistical Analysis of Aging Population in the U.S.
Figure 8: Global Market Segmentation for Cognition and Memory-enhancing Drugs, by Type
Figure 9: Global Market for Cognition and Memory-enhancing Drugs, by Application
Figure 10: The Stages of Alzheimer’s Disease
Figure 11: The Stages of Parkinson’s Disease
Figure 12: U.S. Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 13: Canadian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 14: Mexican Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 15: U.K. Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 16: German Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 17: French Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 18: Rest of Europe Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 19: Chinese Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 20: Japanese Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 21: Australian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 22: Indian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 23: Rest of Asia-Pacific Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 24: Brazilian Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 25: Turkey’s Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 26: South African Market for Cognition and Memory-enhancing Drugs, 2016-2022
Figure 27: Strategies for Global Cognition and Memory-enhancing Drugs Market, 2014-2017
Figure 28: Market Players Adopting Several Strategies for Global Cognition and Memory-enhancing Drugs Market, 2014-2017
